An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cardiovascular Systems, Inc. to Participate at Two Upcoming Healthcare Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Cardiovascular Systems, Inc. (CSII) announced plans to present and host investor meetings at two significant healthcare conferences. The 21st Annual Needham Virtual Healthcare Conference will take place on April 12, 2022, at 10:15 a.m. ET, followed by the BofA Securities 2022 Healthcare Conference on May 10, 2022, at 4:00 p.m. ET. Investors can access live webcasts and replays on the company’s investor relations webpage. CSII focuses on innovative treatment solutions for vascular diseases, particularly through its orbital atherectomy system.
Positive
None.
Negative
None.
ST. PAUL, Minn.--(BUSINESS WIRE)--
Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at two upcoming healthcare conferences. Live webcasts and replays of the presentations will be available on the investor relations section of the corporate website.
21st Annual Needham Virtual Healthcare Conference Tuesday, April 12, 2022 10:15 a.m. ET
BofA Securities 2022 Healthcare Conference
Tuesday, May 10, 2022 4:00 p.m. ET
About Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.
Cardiovascular Systems, Inc. Jack Nielsen Vice President, Investor Relations
& Corporate Communications
(651) 202-4919
j.nielsen@csi360.com
Source: Cardiovascular Systems, Inc.
FAQ
What investor conferences will Cardiovascular Systems, Inc. (CSII) participate in?
Cardiovascular Systems, Inc. will participate in the 21st Annual Needham Virtual Healthcare Conference on April 12, 2022, and the BofA Securities 2022 Healthcare Conference on May 10, 2022.
What is the schedule for CSII's presentations at the upcoming conferences?
CSII's presentation at the Needham Virtual Healthcare Conference is scheduled for April 12, 2022, at 10:15 a.m. ET, and at the BofA Securities Healthcare Conference on May 10, 2022, at 4:00 p.m. ET.
Where can I find the webcasts for CSII's conference presentations?
The live webcasts and replays of CSII's presentations will be available on the investor relations section of the company’s corporate website.
What innovative solutions does Cardiovascular Systems, Inc. (CSII) offer?
CSII develops innovative interventional treatment systems, including an orbital atherectomy system for treating calcified and fibrotic plaque in arterial vessels.
